Ontology highlight
ABSTRACT: Background
Tolerability and antitumour efficacy of chemotherapy and radiation therapy can vary largely according to their time of administration along the 24-h time scale, due to the moderation of their molecular and cellular mechanisms by circadian rhythms. Recent clinical data have highlighted a striking role of dosing time for cancer immunotherapy, thus calling for a critical evaluation.Methods
Here, we review the clinical data and we analyse the mechanisms through which circadian rhythms can influence outcomes on ICI therapies. We examine how circadian rhythm disorders can affect tumour immune microenvironment, as a main mechanism linking the circadian clock to the 24-h cycles in ICIs antitumour efficacy.Results
Real-life data from 18 retrospective studies have
SUBMITTER: Karaboue A
PROVIDER: S-EPMC11369086 | biostudies-literature | 2024 Sep
REPOSITORIES: biostudies-literature